Working with healthcare professionals and organizations

Lundbeck works with healthcare professionals when developing and delivering new treatment options to people living with psychiatric and neurological diseases. We believe this collaborative working benefits patients and society.

Research & Development (R&D)

Lundbeck undertakes research activities and conducts clinical studies globally. Clinical studies are conducted in accordance with international guidelines and performed by HCPs and HCOs. Our payments and other transfers of value related to pre-clinical, clinical and non-interventional studies are disclosed in aggregate.

 

  R&D payments to HCPs & HCOs
Country 2015 2016 
Austria 5.140 EUR See country overview for link to disclosure data
Bulgaria 579.823 EUR 319.234 EUR
Croatia 95.822 HRK 303.693 HRK
Germany 2.812.493 EUR See country overview for link to disclosure data
Hungary 8.507 EUR 30.128 EUR
Latvia See country overview for link to disclosure data 83.105 EUR
Lithuania 403.371 EUR 229.952 EUR
Serbia 251.289 EUR Company closed
Ukraine 896.803 EUR 359.207 EUR

The amounts cover payments and other transfers of value to HCPs and HCOs related to pre-clinical, clinical and non-interventional studies in the countries where the Lundbeck affiliate uses Lundbeck’s corporate website for disclosure in accordance with the EFPIA Disclosure Code.

Data from other countries can be found on the Country overview tab.

Cookie Policy
You have chosen to leave www.lundbeck.com. Lundbeck does not have any responsibility for the content provided by other websites. Click "OK" to continue or "Cancel" to remain on www.lundbeck.com.